Active Ingredient Brentuximab Vedotin

Active Ingredient Details

What is Brentuximab Vedotin?

Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.

What is the usage for Brentuximab Vedotin?

Brentuximab is used to treat certain types of cancers (Hodgkin's lymphoma, systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides). It works by slowing or stopping the growth of cancer cells.

How many products in the NDC database contain Brentuximab Vedotin?

The NDC database has 4 products with the active ingredient Brentuximab Vedotin. The following table lists all the products that have this active ingredient.

NDC Products with Brentuximab Vedotin

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
49187-0212Proprietary Name: Brentuximab VedotinLiquidLonza AgACTIVE
51144-050Proprietary Name: Adcetris Brentuximab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE
69443-050Proprietary Name: Brentuximab VedotinPowder, For SolutionBaxter Oncology GmbhACTIVE
78848-003Proprietary Name: Brentuximab VedotinInjectionFarevaACTIVE